Miles Conrad, MD, MPH is a Clinical Professor in the Department of Radiology at the University of California, San Francisco. In 2001, Dr. Conrad received his MD from Dartmouth Medical School in Hanover, New Hampshire, and in 2002 he obtained his MPH in Quantitative Methods from Harvard School of Public Heath in Boston. He completed his residency in Diagnostic Radiology from the University of Arizona, Tucson, followed by a fellowship in Interventional Radiology from the University of Arizona in 2008.
Dr. Conrad is Co-Director of the UCSF Hereditary Hemorrhagic Telangiectasia Center of Excellence. He specializes in the treatment of pulmonary arteriovenous malformations and revisions of those that have been previously treated and have recurred.
Dr. Conrad has initiated a program for percutanous cryoablation of renal cell carcinomas at San Francisco General Hospital, a cancer that traditionally is resected surgically. He enjoys working closely with other specialties to coordinate care and close the gap between marginalized patients without insurance and those with full access to health care.
Interventional Radiology, Hereditary Hemorrhagic Telangiectasia (HHT)
Lung cancer, liver tumor, liver cancer, HHT
Endovascular embolizations for treatment of trauma, uterine fibroids and liver neoplasms, treatment of deep venous thrombosis, pulmonary embolus, portal hypertension including TIPS, liver, kidney, and lung tumor ablation
Education and Training:
• Medical School: Dartmouth Medical School, Hanover, New Hampshire
• Internship: Virginia Mason Medical Center, Seattle - General Surgery
• Residency: University of Arizona, Tucson - Diagnostic Radiology
• Fellowship: University of Arizona, Tucson - Interventional Radiology
• Masters in Public Health: Harvard School of Public Health, Boston - Quantitative Methods
• American Board of Radiology, Certificate of Additional Qualification - Interventional Radiology
• American Board of Radiology Certification
• Medical licensure, California